Literatur: Clopidogrel

Als Hinweis auf potentielle weitere Informationsquellen. Kein Anspruch auf Vollständigkeit.

 

Clopidogrel

  • 1. "A Randomized, Blinded, Trial of Clopidogrel Versus Aspirin in Patients at Risk of Ischaemic Events (CAPRIE). CAPRIE Steering Committee," Lancet, 1996, 348(9083):1329-39. [PubMed 8918275]
  • 2. Abraham NS, Hlatky MA, Antman EM, et al, “ACCF/ACG/AHA 2010 Expert Consensus Document on the Concomitant Use of Proton Pump Inhibitors and Thienopyridines: A Focused Update of the ACCF/ACG/AHA 2008 Expert Consensus Document on Reducing the Gastrointestinal Risks of Antiplatelet Therapy and NSAID Use: A Report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents,” Circulation, 2010, 122(24):2619-33. [PubMed 21060077]
  • 3. ACTIVE Investigators, Connolly SJ, Pogue J, Hart RG, et al, "Effect of Clopidogrel Added to Aspirin in Patients With Atrial Fibrillation," N Engl J Med, 2009, 360(20):2066-78. [PubMed 19336502]
  • 4. Adams HP, del Zoppo G, Alberts MJ, et al, "Guidelines for the Early Management of Adults With Ischemic Stroke: A Guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups," Stroke, 2007, 38(5):1655-1711. [PubMed 17431204]
  • 5. Anderson JL, Adams CD, Antman EM, et al, "2011 ACCF/AHA Focused Update Incorporated Into the ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines," Circulation, 2011, 123(18):e426-579. [PubMed 21444888]
  • 6. Antman EM, Anbe DT, Armstrong PW, et al, "ACC/AHA 2007 Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1999 Guidelines for the Management of Patients With Acute Myocardial Infarction)," J Am Coll Cardiol, 2004, 44(3):671-719. [PubMed 15358045]
  • 7. Bal dit Sollier C, Mahe I, Berge N, et al, "Reduced Thrombus Cohesion in an ex vivo Human Model of Arterial Thrombosis Induced by Clopidogrel Treatment: Kinetics of the Effect and Influence of Single and Double Loading-Dose Regimens," Thromb Res, 2003, 111(1 -2):19-27. [PubMed 14644074]
  • 8. Bell AD, Roussin A, Cartier R, et al, “The Use of Antiplatelet Therapy in the Outpatient Setting: Canadian Cardiovascular Society Guidelines,” Can J Cardiol, 2011, 27 (Suppl A):1-59. [PubMed 21640290]
  • 9. Berger PB, Bell MR, Rihal CS, et al, "Clopidogrel Versus Ticlopidine After Intracoronary Stent Placement," J Am Coll Cardiol, 1999, 34(7):1891-4. [PubMed 10588199]
  • 10. Bertrand ME, Rupprecht HJ, Urban P, et al, "Double-Blind Study of the Safety of Clopidogrel With and Without a Loading Dose in Combination With Aspirin Compared With Ticlopidine in Combination With Aspirin After Coronary Stenting," Circulation, 2000, 102 (6):624-9. [PubMed 10931801]
  • 11. Bhatt DL, Cryer BL, Contant CF, et al, "Clopidogrel With or Without Omeprazole in Coronary Artery Disease," N Engl J Med, 2010, 363(20):1909-17. [PubMed 20925534]
  • 12. Bhatt DL, Fox KA, Hacke W, et al, "Clopidogrel and Aspirin Versus Aspirin Alone for the Prevention of Atherothrombotic Events," N Engl J Med, 2006, 354(16):1706-17. [PubMed 16531616]
  • 13. Chen ZM, Jiang LX, Chen YP, et al, "Addition of Clopidogrel to Aspirin in 45,852 Patients With Acute Myocardial Infarction: Randomized Placebo-Controlled Trial. COMMIT (ClOpidogrel and Metoprolol in Myocardial Infarction Trial) Collaborative Group," Lancet, 2005, 366(9497):1607-21. [PubMed 16271642]
  • 14. CURRENT-OASIS 7 Investigators, Mehta SR, Bassand JP, et al, "Dose Comparisons of Clopidogrel and Aspirin in Acute Coronary Syndromes," N Engl J Med, 2010, 363(10):930-42. [PubMed 20818903]
  • 15. Desta Z, Zhao X, Shin JG, et al, "Clinical Significance of the Cytochrome P450 2C19 Genetic Polymorphism," Clin Pharmacokinet, 2002, 41(12):913-58. [PubMed 12222994]
  • 16. Fraker TD, Fihn SD, Gibbons RJ, et al, "2007 Chronic Angina Focused Update of the ACC/AHA 2002 Guidelines for the Management of Patients With Chronic Stable Angina: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines Writing Group to Develop the Focused Update of the 2002 Guidelines for the Management of Patients With Chronic Stable Angina," Circulation, 2007, 116(23):2762-72. [PubMed 17998462]
  • 17. Frere C, Cuisset T, Morange PE, et al, "Effect of Cytochrome P450 Polymorphisms on Platelet Reactivity After Treatment with Clopidogrel in Acute Coronary Syndrome," Am J Cardiol, 2008, 101(8):1088-93. [PubMed 18394438]
  • 18. Furie KL, Kasner SE, Adams RJ, et al, "Guidelines for the Prevention of Stroke in Patients With Stroke or Transient Ischemic Attack: A Guideline for Healthcare Professionals from the American Heart Association/American Stroke Association," Stroke, 2011, 42(1):227 -76. [PubMed 20966421]
  • 19. Gibbons RJ, Abrams J, Chatterjee K, et al, "ACC/AHA 2002 Guideline Update for the Management of Patients With Chronic Stable Angina − Summary Article: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Chronic Stable Angina)," Circulation, 2003, 107(1):149-58. [PubMed 12515758]
  • 20. Gilard M, Arnaud B, Cornily JC, et al, "Influence of Omeprazole on the Antiplatelet Action of Clopidogrel Associated With Aspirin: The Randomized, Double-Blind Ocla (Omeprazole Clopidogrel Aspirin) Study," J Am Coll Cardiol, 2008, 51(3):256-60.
  • 21. Gilard M, Arnaud B, Le Gal G, et al, "Influence of Omeprazol on the Antiplatelet Action of Clopidogrel Associated to Aspirin," J Thromb Haemost, 2006, 4(11):2508-9.
  • 22. Grines CL, Bonow RO, Casey DE, et al, "AHA/ACC/SCAI/ACS/ADA Science Advisory, Prevention of Premature Discontinuation of Dual Antiplatelet Therapy in Patients With Coronary Artery Stents. A Science Advisory From the American Heart Association, American College of Cardiology, Society of Cardiovascular Angiography and Interventions, American College of Surgeons, and American Dental Association With Representation from the Amercian College of Physicians," Circulation, 2007, 115(6):813-8. [PubMed 17224480]
  • 23. Guyatt GH, Akl EA, Crowther M, et al, “Executive Summary: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines,” Chest, 2012, 141(2 Suppl):7-47. [PubMed 22315257]
  • 24. Herbert JM, Frehel D, Vallee E, et al, "Clopidogrel, A Novel Antiplatelet and Antithrombotic Agent," Cardiovascular Drug Rev, 1993, 11(2):180-98.
  • 25. Hillis LD, Smith PK, Anderson JL, et al, “2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines,” Circulation, 2011, 124(23):2610-42. [PubMed 22064600]
  • 26. Hirsch AT, Haskal ZJ, Hertzer NR, et al, “ACC/AHA 2005 Practice Guidelines for the Management of Patients With Peripheral Arterial Disease (Lower Extremity, Renal, Mesenteric, and Abdominal Aortic). A Collaborative Report of the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease),” Circulation , 2006, 113 (11):e463-654. [PubMed 16549646]
  • 27. Ho PM, Maddox TM, Wang L, et al, "Risk of Adverse Outcomes Associated With Concomitant Use of Clopidogrel and Proton Pump Inhibitors Following Acute Coronary Syndrome," JAMA, 2009, 301(9):937-44.
  • 28. Hochholzer W, Trenk D, Fromm MF, et al, "Impact of Cytochrome P450 2C19 Loss-of- Function Polymorphism and of Major Demographic Characteristics on Residual Platelet Function After Loading and Maintenance Treatment with Clopidogrel in Patients Undergoing Elective Coronary Stent Placement," J Am Coll Cardiol, 2010, 55(22):2427-34. [PubMed 20510210]
  • 29. Hochholzer W, Trenk D, Frundi D, et al, "Time Dependence of Platelet Inhibition After a 600-mg Loading Dose of Clopidogrel in a Large, Unselected Cohort of Candidates for Percutaneous Coronary Intervention," Circulation, 2005, 111(20):2560-4. [PubMed 15809367]
  • 30. Holmes DR, Dehmer GJ, Kaul S, et al, "ACCF/AHA Clopidogrel Clinical Alert: Approaches to the FDA 'Boxed Warning.' A Report of the American College of Cardiology Foundation Task Force," J Am Coll Cardiol, 2010, 56(4):321-41. [PubMed 20585015]
  • 31. Juurlink DN, Gomes T, Ko DT, et al, "A Population-Based Study of the Drug Interaction Between Proton Pump Inhibitors and Clopidogrel," CMAJ, 2009, 180(7):713-8. [PubMed 19176635]
  • 32. Kastrati A, Mehilli J, Schuhlen H, et al, "A Clinical Trial of Abciximab in Elective Percutaneous Coronary Intervention After Pretreatment With Clopidogrel," N Engl J Med, 2004, 350(3):232-8. [PubMed 14724302]
  • 33. Kreutz RP, Stanek EJ, Aubert R, et al, "Impact of Proton Pump Inhibitors on the Effectiveness of Clopidogrel After Coronary Stent Placement: The Clopidogrel Medco Outcomes Study," Pharmacotherapy, 2010, 30(8):787-96. [PubMed 20653354]
  • 34. Lange RA and Hillis LD, "Antiplatelet Therapy for Ischemic Heart Disease," N Engl J Med, 2004, 350(3):277-80. [PubMed 14724308]
  • 35. Levine GN, Bates ER, Blankenship JC, et al, “2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions,” Circulation, 2011, 124(23):e574-651. [PubMed 22064601]
  • 36. Lidell C, Svedberg LE, Lindell P, et al, "Clopidogrel and Warfarin: Absence of Interaction in Patients Receiving Long-Term Anticoagulant Therapy for Nonvalvular Atrial Fibrillation," Thromb Haemost, 2003, 89(5):842-6. [PubMed 12719782]
  • 37. Li XQ, Andersson TB, Ahalström M, et al, "Comparison of Inhibitory Effects of the Proton Pump-Inhibiting Drugs Omeprazole, Esomeprazole, Lansoprazole, Pantoprazole and Rabeprazole on Human Cytochrome P450 Activities," Drug Metab Dispo, 2004, 32(8):821-7. [PubMed 15258107]
  • 38. Mega JL, Close SL, Wiviott SD, et al, "Cytochrome P-450 Polymorphisms and Response to Clopidogrel," N Engl J Med, 2009, 360(40):354-62. [PubMed 19106084]
  • 39. Mehta SR, Yusuf S, Peters RJ, et al, "Effects of Pretreatment With Clopidogrel and Aspirin Followed by Long-Term Therapy in Patients Undergoing Percutaneous Coronary Intervention: The PCI-CURE Study," Lancet, 2001, 358(9281):527-33. [PubMed 11520521]
  • 40. Mishkel GJ, Aguirre FV, Ligon RW, et al, "Clopidogrel as Adjunctive Antiplatelet Therapy During Coronary Stenting," J Am Coll Cardiol, 1999, 34(7):1884-90. [PubMed 10588198]
  • 41. Montalescot G, Sideris G, Meuleman C, et al, "A Randomized Comparison of High Clopidogrel Loading Doses in Patients With Non-ST-Segment Elevation Acute Coronary Syndromes," J Am Coll Cardiol, 2006, 48(5):931-8. [PubMed 16949482]
  • 42. Moussa I, Oetgen M, Roubin G, et al, "Effectiveness of Clopidogrel and Aspirin Versus Ticlopidine and Aspirin in Preventing Stent Thrombosis After Coronary Stent Implantation," Circulation, 1999, 99(18):2364-6. [PubMed 10318654]
  • 43. O’Donoghue ML, Braunwald E, Antman EM, et al, "Pharmacodynamic Effect and Clinical Efficacy of Clopidogrel and Prasugrel with or without a Proton-pump Inhibitor: an Analysis of Two Randomised Trials," Lancet, 2009, 374(9694):989-97. [PubMed 19726078]
  • 44. Patti G, Colonna G, Pasceri V, et al, "Randomized Trial of High Loading Dose of Clopidogrel for Reduction of Periprocedural Myocardial Infarction in Patients Undergoing Coronary Intervention: Results From the ARMYDA-2 (Antiplatelet Therapy for Reduction of Myocardial Damage During Angioplasty) Study," Circulation, 2005, 111(16):2099-106.
  • 45. Pezalla E, Day D, and Pulliadath I, "Initial Assessment of Clinical Impact of a Drug Interaction Between Clopidogrel and Proton Pump Inhibitors," J Am Coll Cardiol, 2008, 52(12):1038-9.
  • 46. Price MJ, Berger PB, Teirstein PS, et al, "Standard- Vs High-Dose Clopidogrel Based on Platelet Function Testing After Percutaneous Coronary Intervention: The GRAVITAS Randomized Trial," JAMA, 2011, 305(11):1097-105. [PubMed 21406646]
  • 47. Rooke TW, Hirsch AT, Misra S, et al, “2011 ACCF/AHA Focused Update of the Guideline for the Management of Patients With Peripheral Artery Disease (Updating the 2005 Guideline): A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines,” Circulation, 2011, 124(18):2020-45. [PubMed 21959305]
  • 48. Sabatine MS, Cannon CP, Gibson CM, et al, "Addition of Clopidogrel to Aspirin and Fibrinolytic Therapy for Myocardial Infarction With ST-Segment Elevation," N Engl J Med, 2005, 352(12):1179-89. [PubMed 15758000]
  • 49. Scirica BM, Sabatine MS, Morrow DA, et al, "The Role of Clopidogrel in Early and Sustained Arterial Patency After Fibrinolysis for ST-segment Elevation Myocardial Infarction. The ECG Clarity-TIMI 28 Study," J Am Coll Cardiol, 2006, 48(1):37-42. [PubMed 16814646]
  • 50. Sibbing D, Koch W, Gebhard D, et al, "Cytochrome 2C19*17 Allelic Variant, Platelet Aggregation, Bleeding Events, and Stent Thrombosis in Clopidogrel-Treated Patients With Coronary Stent Placement," Circulation, 2010, 121(4):512-18. [PubMed 20083681]
  • 51. Siller-Matula JM, Spiel AO, Lang IM, et al, "Effects of Pantoprazole and Esomeprazole on Platelet Inhibition by Clopidogrel," Am Heart J, 2009, 157(1):148.e1- 5.
  • 52. Sim SC, Risinger C, Dahl ML, et al, "A Common Novel CYP2C19 Gene Variant Causes Ultrarapid Drug Metabolism Relevant for the Drug Response to Proton Pump Inhibitors and Antidepressants," Clin Pharmacol Ther, 2006, 79(1):103-13. [PubMed 16413245]
  • 53. Skanes AC, Healey JS, Cairns JA, et al, “Focused 2012 Update of the Canadian Cardiovascular Society Atrial Fibrillation Guidelines: Recommendations for Stroke Prevention and Rate/Rhythm Control,” Can J Cardiol, 2012, 28(2):125-36. [PubMed 22433576]
  • 54. Small DS, Farid NA, Payne CD, et al, "Effects of the Proton Pump Inhibitor Lansoprazole on the Pharmacokinetics and Pharmacodynamics of Prasugrel and Clopidogrel," J Clin Pharmacol, 2008, 48(4):475-84.
  • 55. Smith SC Jr, Benjamin EJ, Bonow RO, et al, “AHA/ACCF Secondary Prevention and Risk Reduction Therapy for Patients With Coronary and Other Atherosclerotic Vascular Disease: 2011 Update: A Guideline From the American Heart Association and American College of Cardiology Foundation,” Circulation, 2011, 124(22):2458-73. [PubMed 22052934]
  • 56. Steinhubl SR, Berber PB, Mann JT, et al, "Early and Sustained Dual Oral Antiplatelet Therapy Following Percutaneous Coronary Intervention. A Randomized Controlled Trial," JAMA, 2002, 288(19):2411-20. [PubMed 12435254]
  • 57. Trenk D, Hochholzer W, Fromm MF, et al, "Cytochrome P450 2C19 681G>A Polymorphism and High On-Clopidogrel Platelet Reactivity Associated With Adverse 1-Year Clinical Outcome of Elective Percutaneous Coronary Intervention With Drug Eluting or Bare-Metal Stents," J Am Coll Cardiol, 2008, 51(20):1925-34. [PubMed 18482659]
  • 58. Wright RS, Anderson JL, Adams CD, et al, "2011 ACCF/AHA Focused Update of the Guidelines for the Management of Patients with Unstable Angina/Non-ST-Elevation Myocardial Infarction (Updating the 2007 Guideline): A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Developed in Collaboration With the American College of Emergency Physicians, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons," J Am Coll Cardiol, 2011, 57(19):1920-59. [PubMed 21450428]
  • 59. Yusuf S, Zhao F, Mehta SR, et al, "Effects of Clopidogrel in Addition to Aspirin in Patients With Acute Coronary Syndromes Without ST-Segment Elevation," N Engl J Med, 2001, 345(7):494-502. [PubMed 11519503]
  • 60. Wiviott SD, Braunwald E, McCabe CH, et al, “Prasugrel versus Clopidogrel in Patients With Acute Coronary Syndromes,” N Engl J Med, 2007, 357(20):2001-15. [PubMed 17982182]

 

  top |

 

 
© 2018 Prof. Dr. J. Braun